| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.5 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |